Monitoring the treatment of carcinoid disease using blood serotonin and plasma 5-hydroxyindoleacetic acid: Three case examples

Annals of Clinical Biochemistry

Volumn 44, Issue 3, 2007, Pages 300-307

  Allen, K R ^a   Degg, T J ^a   Anthoney, D A ^b   Fitzroy Smith, D ^c  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

^c Countess of Chester Hospital ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANGIOPEPTIN; CHROMOGRANIN A; CHROMOGRANIN B; INTERFERON; OCTREOTIDE; PENTETREOTIDE; SEROTONIN; SOMATULINE AUTOGEL; ALPHA INTERFERON; DRUG DERIVATIVE; SOMATOSTATIN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CANCER SURGERY; CARCINOID; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; FEMALE; HISTOPATHOLOGY; HUMAN; INTESTINE TUMOR; LABORATORY TEST; MALE; MONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEROTONIN BLOOD LEVEL; THROMBOCYTE; THROMBOCYTE COUNT; TREATMENT RESPONSE; TUMOR BIOPSY; BLOOD; MIDDLE AGED;

AGED; CARCINOID TUMOR; HUMANS; HYDROXYINDOLEACETIC ACID; INTERFERON-ALPHA; MALE; MIDDLE AGED; SEROTONIN; SOMATOSTATIN;

EID: 34250310073     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456307780480936     Document Type: Article

References (30)